Showing results (71-80 of 174) with videos related to
Sort By:
Pageof 18
Cancer Epidemiology|April 16, 2026
Prevalence of Veteran-reported treatment barriers from the breast and gynecologic oncology system of excellenceImari Z Smith, Leah L Zullig, Theodore S Berkowitz, et al.Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.Oral Oncology|September 5, 2020
Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group studyRichard J Young, Benjamin Solomon, June Corry, et al.Molecular Cancer Research : MCR|October 20, 2011
Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cellsArun Azad, Susan Jackson, Carleen Cullinane, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinomaRichard J Young, Danny Rischin, Richard Fisher, et al.Pathology|February 23, 2021
Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide bindingJames A Kuzich, Sarah Heynemann, Niall Geoghegan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid CarcinomaAnnette M Lim, Graham R Taylor, Andrew Fellowes, et al.Oral Oncology|November 22, 2025
Evaluating CD103+ intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal CancerChia Yuen Chong, Richard J Young, Annette M Lim, et al.British Journal of Cancer|July 21, 2017
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancerMarliese Alexander, Rory Wolfe, David Ball, et al.Plos One|November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-RadiotherapyShu Wen Wen, Sarah J Everitt, Justin Bedő, et al.Pageof 18